Duke Energy’s board of directors recently revealed the appointment of Robert Davis, chief financial officer and executive vice president of global services at healthcare company Merck & Co., Inc., as a new board member, effective Jan. 8, 2018. Davis will serve on two Duke Energy board committees: audit, and finance and risk management. He joined Merck in 2014.
Prior to Merck, he worked for Baxter, International Inc., where he served as the company’s corporate vice president and president of Medical Products from 2010 through 2014. In that role, he oversaw a range of businesses with products used in the delivery of fluids and drugs to patients, and in the treatment of end-stage kidney disease.
Prior to that position, Davis served as corporate vice president and president of Baxter’s renal business. He served as Baxter’s corporate vice president and chief financial officer from 2006 through 2010, and the company’s treasurer from 2004 through 2006. Prior to joining Baxter, Davis worked at Eli Lilly and Co., where he held numerous positions of increasing responsibility over 14 years.He has served on the board of directors for C.R. Bard, Inc., since 2015, and is a member of its finance, audit, and science and technology committees.
Davis earned his J.D. degree from Northwestern University School of Law, and his MBA from Northwestern University’s Kellogg Graduate School of Management, after graduating from Miami University with a bachelor’s degree in finance.